Detalles de la búsqueda
1.
Effect of an NHE3 inhibitor in combination with an NPT2b inhibitor on gastrointestinal phosphate absorption in Rodent models.
PLoS One
; 19(1): e0292091, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38277356
2.
Effects of pharmacological inhibition of the sodium-dependent phosphate cotransporter 2b (NPT2b) on intestinal phosphate absorption in mouse and rat models.
Pharmacol Res Perspect
; 10(2): e00938, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35194979
3.
Quantitative sphingosine measurement as a surrogate for total ceramide concentration-preclinical and potential translational applications.
Biomed Chromatogr
; 24(7): 752-8, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19908207
4.
Estimating the distribution of a novel clinical biomarker (FGF-23) in the US population using findings from a regional research registry.
PLoS One
; 14(6): e0218435, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31246994
5.
Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.
J Med Chem
; 51(5): 1145-9, 2008 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-18260618
6.
Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice.
Diabetes
; 55(1): 240-8, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16380499
7.
Design and synthesis of N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5- methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [Muraglitazar/BMS-298585], a novel peroxisome proliferator-activated receptor alpha/gamma dual agonist with efficacious glucose and lipid-lowering activities.
J Med Chem
; 48(6): 2248-50, 2005 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-15771468
8.
Opportunities for pharmacotherapy at the intersection of metabolic syndrome and hemostasis.
Curr Pharm Biotechnol
; 12(9): 1463-80, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21401518
9.
Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats.
Diabetes
; 57(6): 1723-9, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18356408
10.
5-Carboxamido-1,3,2-dioxaphosphorinanes, potent inhibitors of MTP.
Bioorg Med Chem Lett
; 14(20): 5067-70, 2004 Oct 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-15380200
11.
Microsomal triglyceride transfer protein inhibitors: discovery and synthesis of alkyl phosphonates as potent MTP inhibitors and cholesterol lowering agents.
Bioorg Med Chem Lett
; 13(7): 1337-40, 2003 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-12657277
Resultados
1 -
11
de 11
1
Próxima >
>>